| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.077 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |